{
  "cik": 1861560,
  "cik_padded": "0001861560",
  "entityName": "Nuvalent, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-073317",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 261745000.0,
        "eps_diluted": -5.85,
        "net_income": -425377000.0,
        "operating_cash_flow": -275209000.0,
        "operating_income": -414307000.0,
        "stockholders_equity": 1248339000.0,
        "total_assets": 1412705000.0,
        "total_liabilities": 164366000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13166776011964698,
        "roa_avg2y": -0.3330469058590534,
        "roa_period_end": -0.3011081577540959,
        "roe_avg2y": -0.3669999667835856,
        "roe_period_end": -0.340754394439331
      }
    },
    {
      "accn": "0001193125-26-073317",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 145691000.0,
        "eps_diluted": -3.93,
        "net_income": -260756000.0,
        "operating_cash_flow": -185064000.0,
        "operating_income": -280368000.0,
        "stockholders_equity": 1069792000.0,
        "total_assets": 1141752000.0,
        "total_liabilities": 71960000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06726541234183842,
        "roa_avg2y": -0.2782679592089368,
        "roa_period_end": -0.22838234572831928,
        "roe_avg2y": -0.29458079829276984,
        "roe_period_end": -0.24374457838533098
      }
    },
    {
      "accn": "0001193125-26-073317",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 335387000.0,
        "eps_diluted": -2.17,
        "net_income": -126219000.0,
        "operating_cash_flow": -99739000.0,
        "operating_income": -149492000.0,
        "stockholders_equity": 700561000.0,
        "total_assets": 732384000.0,
        "total_liabilities": 31823000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04542502365960994,
        "roa_avg2y": -0.20779475207907525,
        "roa_period_end": -0.1723399200419452,
        "roe_avg2y": -0.216957059453959,
        "roe_period_end": -0.18016846498734584
      }
    },
    {
      "accn": "0001193125-26-073317",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 241806000.0,
        "eps_diluted": -1.65,
        "net_income": -81854000.0,
        "operating_cash_flow": -64971000.0,
        "operating_income": -86108000.0,
        "stockholders_equity": 462978000.0,
        "total_assets": 482459000.0,
        "total_liabilities": 19481000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04207759331976897,
        "roa_avg2y": -0.21088700899027804,
        "roa_period_end": -0.16966001256065283,
        "roe_avg2y": -0.2188565737318102,
        "roe_period_end": -0.17679889757180686
      }
    },
    {
      "accn": "0000950170-25-028328",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 68526000.0,
        "eps_diluted": -2.13,
        "net_income": -46338000.0,
        "operating_cash_flow": -40000000.0,
        "operating_income": -45817000.0,
        "stockholders_equity": 285037000.0,
        "total_assets": 293824000.0,
        "total_liabilities": 8787000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.030827576770735027,
        "roa_avg2y": -0.3043846684402404,
        "roa_period_end": -0.15770665432367675,
        "roe_avg2y": -0.36527743837549365,
        "roe_period_end": -0.16256836831709567
      }
    },
    {
      "accn": "0000950170-23-008284",
      "filed": "2023-03-16",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 10332000.0,
        "eps_diluted": -5.08,
        "net_income": -14556000.0,
        "operating_cash_flow": -14949000.0,
        "operating_income": -16905000.0,
        "stockholders_equity": -31323000.0,
        "total_assets": 10646000.0,
        "total_liabilities": 6615000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -1.3672740935562653,
        "roe_avg2y": 0.5992712900636077
      }
    },
    {
      "accn": "0001193125-22-087401",
      "filed": "2022-03-29",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "cash": 3016000.0,
        "stockholders_equity": -17256000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-073317",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001861560.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001861560.json"
  },
  "ticker": "NUVL"
}